Chemodenervation is Associated With Reduced Mental Health Disorders in Patients With Synkinesis
Otolaryngology–Head and Neck Surgery · 2024
DOI: 10.1002/ohn.936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2024. Verfasst von Fred Jeffrey Lorenz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Penn State Hershey Medical Center, Hershey, Pennsylvania, USA. Hauptthemen laut MEDLINE: Facial Paralysis, Synkinesis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
Objective
To compare the prevalence of mental health disorders in individuals with facial synkinesis, facial paralysis alone, and the general population. Study Design Retrospective cohort.
Setting
Eighty‐two health care organizations across the United States.
Methods
The TriNetX Research Network was queried from 2011 to 2021 for patients with facial paralysis without synkinesis, facial paralysis and documented synkinesis, and controls, matched for age, sex, race, and ethnicity. Cases included infectious, iatrogenic, or idiopathic facial paralysis. Patients with pre‐existing depression or anxiety were excluded. Two‐year rates of newly diagnosed depression, anxiety, and mental health prescriptions were compared.
Results
Among 127,573 patients with facial paralysis, 92.5% (n = 117,976) had facial paralysis alone, and 7.5% (n = 9597) also had documented synkinesis. Compared to controls, patients with facial paralysis alone had increased risks of new depression (8.9% vs 7.3%, P < .001) and anxiety (10.1% vs 9.6%, P < .001), with higher mental health medication rates (16.6% vs 13.1%, P < .001). Patients with documented synkinesis, in comparison to controls, had the highest risks of depression (19.8% vs 8.6%, P < .001), anxiety (20.5% vs 10.5%, P < .001), and prescriptions (28.1% vs 15.8%, P < .001). The 27.8% (n = 2669) of synkinetic patients treated with chemodenervation had lower rates of depression (8.5% vs 23.5%, P < .001), anxiety (9.0% vs 23.8%, P < .001), and prescriptions (21.6% vs 30.0%, P < .001) compared to synkinetic patients who were not.
Conclusion
Facial paralysis, particularly synkinesis, is linked to increased mental health disorders. Integrating mental health screening and treatment into a comprehensive approach is crucial. Chemodenervation is associated with decreased mental health disorders in synkinesis, highlighting its therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Penn State Hershey Medical Center, Hershey, Pennsylvania, USA.
ORCID-Profile: Jessyka G Lighthall
Förderung
- NCATS NIH HHS
Zitieren
APA
Lorenz, F. J., Schopper, H. K., & Lighthall, J. G. (2024). Chemodenervation is Associated With Reduced Mental Health Disorders in Patients With Synkinesis. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.936
Vancouver
Lorenz FJ, Schopper HK, Lighthall JG. Chemodenervation is Associated With Reduced Mental Health Disorders in Patients With Synkinesis. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.936
BibTeX
@article{Lorenz2024,
author = {Lorenz, Fred Jeffrey and Schopper, Heather K and Lighthall, Jessyka G},
title = {Chemodenervation is Associated With Reduced Mental Health Disorders in Patients With Synkinesis},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
doi = {10.1002/ohn.936}
}
EUVIMED